Department of Ophthalmology, Meir Medical Center, 59 Tshernehovsky St, 4428164, Kfar Saba, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):927-935. doi: 10.1007/s00417-023-06265-0. Epub 2023 Oct 16.
Intraocular pressure (IOP) spikes (IOP > 30 mmHg or > 10 mmHg above baseline IOP) are a common and worrisome complication of gonioscopy-assisted transluminal trabeculotomy (GATT). The purpose of this study is to identify risk factors for IOP spikes and to describe their characteristics, management, and clinical course in a large cohort of patients.
A retrospective, single-center study which included 217 consecutive eyes of patients that underwent GATT between December 2019 and April 2022 with follow-up of at least 90 days.
IOP spikes occurred in 52 of 217 (24%) eyes. Spikes occurred in 15.5% of patients in whom pre-operative IOP-lowering medications were continued after surgery (90 eyes), and in 29.9% in whom IOP-lowering medications were stopped after surgery (127 eyes). Spikes were diagnosed at a mean of 7.7 ± 6.5 days after surgery. All IOP spikes occurred within the first month of surgery. The mean duration of a spike was 4.9 ± 5.4 days. Management of IOP spikes included adding a mean of 3.13 ± 1.7 groups of glaucoma medications. Thirty-seven (72.5%) eyes were treated with oral carbonic anhydrase inhibitor, 11 (21.6%) were treated with IV mannitol, and anterior chamber paracentesis was performed in 16 (31.4%). Six (11.8%) eyes underwent additional glaucoma surgery to control IOP. Patients that continued their pre-operative IOP-lowering medications after surgery were 2.3 times less likely to develop a spike as compared to patients who discontinued their medications (P = 0.016). Spikes were found to be a risk factor for failure of GATT.
IOP spikes are a common occurrence after GATT. They most commonly appear during the first two post-operative weeks and usually resolve with topical and systemic IOP-lowering treatment. The continuation of IOP-lowering medications after GATT is recommended to lower the risk of IOP spikes.
眼内压(IOP)峰值(IOP>30mmHg 或比基线 IOP 高 10mmHg 以上)是房角镜辅助经巩膜隧道小梁切开术(GATT)的常见且令人担忧的并发症。本研究的目的是确定 IOP 峰值的危险因素,并描述其在大量患者中的特征、处理和临床过程。
这是一项回顾性、单中心研究,纳入了 2019 年 12 月至 2022 年 4 月期间接受 GATT 的 217 例连续患者的 217 只眼,随访时间至少为 90 天。
217 只眼中有 52 只(24%)发生了 IOP 峰值。在继续使用术前降眼压药物的患者中,IOP 峰值发生率为 15.5%(90 只眼),而在停止使用术前降眼压药物的患者中,IOP 峰值发生率为 29.9%(127 只眼)。IOP 峰值在术后平均 7.7±6.5 天被诊断。所有 IOP 峰值均发生在手术的第一个月内。IOP 峰值的平均持续时间为 4.9±5.4 天。IOP 峰值的处理方法包括平均加用 3.13±1.7 组降眼压药物。37 只(72.5%)眼接受口服碳酸酐酶抑制剂治疗,11 只(21.6%)眼接受 IV 甘露醇治疗,16 只(31.4%)眼行前房穿刺术。6 只(11.8%)眼因眼压控制不佳而接受额外的青光眼手术。与停止术前降眼压药物的患者相比,继续使用术前降眼压药物的患者发生 IOP 峰值的可能性低 2.3 倍(P=0.016)。IOP 峰值是 GATT 失败的危险因素。
IOP 峰值是 GATT 后的常见现象。它们最常出现在术后前两周,通常通过局部和全身降眼压治疗即可缓解。建议 GATT 后继续使用降眼压药物以降低 IOP 峰值的风险。